Ontrak - OTRK Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ontrak in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" OTRK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OTRK, but not buy additional shares or sell existing shares.
View OTRK analyst ratings or view top-rated stocks.

3 brokerages have issued 1 year target prices for Ontrak's stock. Their OTRK share price forecasts range from $1.30 to $15.00. On average, they expect the company's share price to reach $5.45 in the next twelve months. This suggests a possible upside of 607.3% from the stock's current price.
View analysts price targets for OTRK or view top-rated stocks among Wall Street analysts.

Ontrak's stock was trading at $6.29 at the beginning of the year. Since then, OTRK shares have decreased by 87.8% and is now trading at $0.7705.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our OTRK earnings forecast.

Ontrak, Inc. (NASDAQ:OTRK) posted its quarterly earnings results on Thursday, November, 5th. The company reported ($0.20) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.20). The firm earned $24.02 million during the quarter. Ontrak had a negative trailing twelve-month return on equity of 127.01% and a negative net margin of 151.33%.
Read the conference call transcript.

Ontrak updated its FY 2022 earnings guidance on Tuesday, August, 16th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $14.00 million-$16.00 million, compared to the consensus revenue estimate of $25.17 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other Ontrak investors own include NVIDIA (NVDA), Inseego (INSG), JD.com (JD), Livongo Health (LVGO), Advanced Micro Devices (AMD), Alibaba Group (BABA), Marvell Technology (MRVL), Block (SQ), BioXcel Therapeutics (BTAI) and Salesforce (CRM).

Ontrak trades on the NASDAQ under the ticker symbol "OTRK."

Ontrak's stock is owned by a number of retail and institutional investors. Top institutional investors include Russell Investments Group Ltd. (7.58%), Millennium Management LLC (0.45%), Renaissance Technologies LLC (0.32%), AQR Capital Management LLC (0.19%), State Street Corp (0.14%) and 180 Wealth Advisors LLC (0.15%). Insiders that own company stock include Arik Hill, Curtis Medeiros, David M Tullio, Frank Clyburn and Terren S Peizer.
View institutional ownership trends.

Shares of OTRK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of OTRK stock can currently be purchased for approximately $0.77.

Ontrak (NASDAQ:OTRK) has a market capitalization of $20.05 million and generates $84.13 million in revenue each year. The company earns $-37,140,000.00 in net income (profit) each year or ($3.30) on an earnings per share basis.

The company employs 724 workers across the globe.

Ontrak's mailing address is 2120 COLORADO AVE SUITE 230, SANTA MONICA CA, 90404. The official website for the company is ontrakhealth.com. The company can be reached via phone at (310) 444-4300, via email at aprior@equityny.com, or via fax at 888-975-7712.